'''BufferGel''' is the brand name of a [[spermicide]] and [[microbicide]] gel which is being tested for its potential development into a preventative medicine to stop the transmission of [[HIV]].

==Testing==
In macaques, after BufferGel's effect on [[microflora]] and [[pH]] were measured by vaginal [[colposcopy]] and [[rectal lavage]] researchers determined that it fit the safety profile of a drug which could be tested on humans.<ref name="macaque">{{cite pmid|11460027}}</ref>

A phase I clinical trial done on women in India, Thailand gave supporting evidence that users tolerate the drug well.<ref>{{cite journal|last=Wijgert|first=Janneke van de|coauthors=Andrew Fullem, Clifton Kelly, Sanjay Mehendale, Sungwal Rugpao, Newton Kumwenda, Zvavahera Chirenje, Smita Joshi, Nancy Padian, Robert Bollinger, and Kenrad Nelson|title=Phase 1 Trial of the Topical Microbicide BufferGel: Safety Results From Four International Sites|journal=Journal of Acquired Immune Deficiency Syndromes|year=2001|volume=26|issue=1|pages=21â€“27|url=http://journals.lww.com/jaids/Abstract/2001/01010/Phase_1_Trial_of_the_Topical_Microbicide.3.aspx|publisher=Lippincott Williams & Wilkins|location=Philadelphia}}</ref>  A similar trial in the United States also showed drug tolerance.<ref>{{cite doi|10.1086/318496}}</ref>

==References==
{{reflist}}

==External links==
*[http://www.reprotect.com/products.shtml manufacturer's product page]

{{Microbicides for sexually transmitted diseases}}
[[Category:Microbicides]]
[[Category:Spermicide]]